134 related articles for article (PubMed ID: 15812530)
1. Stem cell transplantation for congenital immunodeficiencies using reduced-intensity conditioning.
Veys P; Rao K; Amrolia P
Bone Marrow Transplant; 2005 Mar; 35 Suppl 1():S45-7. PubMed ID: 15812530
[TBL] [Abstract][Full Text] [Related]
2. Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative protocol.
Alvarez I; Sureda A; Caballero MD; Urbano-Ispizua A; Ribera JM; Canales M; García-Conde J; Sanz G; Arranz R; Bernal MT; de la Serna J; Díez JL; Moraleda JM; Rubió-Félix D; Xicoy B; Martínez C; Mateos MV; Sierra J
Biol Blood Marrow Transplant; 2006 Feb; 12(2):172-83. PubMed ID: 16443515
[TBL] [Abstract][Full Text] [Related]
3. Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation.
Jiménez M; Martínez C; Ercilla G; Carreras E; Urbano-Ispízua A; Aymerich M; Villamor N; Amézaga N; Rovira M; Fernández-Avilés F; Gaya A; Martino R; Sierra J; Montserrat E
Exp Hematol; 2005 Oct; 33(10):1240-8. PubMed ID: 16219547
[TBL] [Abstract][Full Text] [Related]
4. Does haploidentical transplantation in children with primary immunodeficiencies have the potential to exploit donor NK cell alloreactivity?
Dal-Cortivo L; Ouachée-Chardin M; Hirsch I; Blanche S; Fischer A; Cavazzana-Calvo M; Caillat-Zucman S
Bone Marrow Transplant; 2004 Dec; 34(11):945-7. PubMed ID: 15489880
[TBL] [Abstract][Full Text] [Related]
5. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Uzunel M; Remberger M; Sairafi D; Hassan Z; Mattsson J; Omazic B; Barkholt L; Ringdén O
Transplantation; 2006 Oct; 82(7):913-9. PubMed ID: 17038906
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
Remberger M; Mattsson J; Hassan Z; Karlsson N; LeBlanc K; Omazic B; Okas M; Sairafi D; Ringdén O
Bone Marrow Transplant; 2008 Feb; 41(4):399-405. PubMed ID: 17982493
[TBL] [Abstract][Full Text] [Related]
7. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens.
Jiménez M; Ercilla G; Martínez C
Leukemia; 2007 Aug; 21(8):1628-37. PubMed ID: 17525730
[TBL] [Abstract][Full Text] [Related]
9. Unrelated cord blood transplantation for severe combined immunodeficiency and other primary immunodeficiencies.
Díaz de Heredia C; Ortega JJ; Díaz MA; Olivé T; Badell I; González-Vicent M; Sánchez de Toledo J
Bone Marrow Transplant; 2008 Apr; 41(7):627-33. PubMed ID: 18084339
[TBL] [Abstract][Full Text] [Related]
10. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Conrad R; Remberger M; Cederlund K; Ringdén O; Barkholt L
Haematologica; 2008 Feb; 93(2):265-72. PubMed ID: 18245651
[TBL] [Abstract][Full Text] [Related]
11. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases.
Satwani P; Cooper N; Rao K; Veys P; Amrolia P
Bone Marrow Transplant; 2008 Jan; 41(2):173-82. PubMed ID: 18037944
[TBL] [Abstract][Full Text] [Related]
12. Reduced-intensity conditioning compared with conventional allogeneic stem-cell transplantation in relapsed or refractory Hodgkin's lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation.
Sureda A; Robinson S; Canals C; Carella AM; Boogaerts MA; Caballero D; Hunter AE; Kanz L; Slavin S; Cornelissen JJ; Gramatzki M; Niederwieser D; Russell NH; Schmitz N
J Clin Oncol; 2008 Jan; 26(3):455-62. PubMed ID: 18086796
[TBL] [Abstract][Full Text] [Related]
13. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen.
Rao K; Amrolia PJ; Jones A; Cale CM; Naik P; King D; Davies GE; Gaspar HB; Veys PA
Blood; 2005 Jan; 105(2):879-85. PubMed ID: 15367433
[TBL] [Abstract][Full Text] [Related]
14. Nonmyeloablative stem cell transplantation for nonmalignant diseases in children with severe organ dysfunction.
Kikuta A; Ito M; Mochizuki K; Akaihata M; Nemoto K; Sano H; Ohto H
Bone Marrow Transplant; 2006 Nov; 38(10):665-9. PubMed ID: 17013427
[TBL] [Abstract][Full Text] [Related]
15. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning.
Steiner M; Matthes-Martin S; Attarbaschi A; Minkov M; Grois N; Unger E; Holter W; Vormoor J; Wawer A; Ouachee M; Woessmann W; Gadner H
Bone Marrow Transplant; 2005 Aug; 36(3):215-25. PubMed ID: 15937510
[TBL] [Abstract][Full Text] [Related]
16. Rapid immune reconstitution after a reduced-intensity conditioning regimen and a CD3-depleted haploidentical stem cell graft for paediatric refractory haematological malignancies.
Chen X; Hale GA; Barfield R; Benaim E; Leung WH; Knowles J; Horwitz EM; Woodard P; Kasow K; Yusuf U; Behm FG; Hayden RT; Shurtleff SA; Turner V; Srivastava DK; Handgretinger R
Br J Haematol; 2006 Nov; 135(4):524-32. PubMed ID: 17010105
[TBL] [Abstract][Full Text] [Related]
17. Stem cell transplantation for children with Glanzmann thrombasthenia.
Connor P; Khair K; Liesner R; Amrolia P; Veys P; Ancliff P; Mathias M
Br J Haematol; 2008 Mar; 140(5):568-71. PubMed ID: 18205861
[TBL] [Abstract][Full Text] [Related]
18. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
19. Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignancies.
Corradini P; Zallio F; Mariotti J; Farina L; Bregni M; Valagussa P; Ciceri F; Bacigalupo A; Dodero A; Lucesole M; Patriarca F; Rambaldi A; Scimè R; Locasciulli A; Bandini G; Gianni AM; Tarella C; Olivieri A
J Clin Oncol; 2005 Sep; 23(27):6690-8. PubMed ID: 16170177
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic stem cell transplantation for primary immunodeficiency disease.
Dvorak CC; Cowan MJ
Bone Marrow Transplant; 2008 Jan; 41(2):119-26. PubMed ID: 17968328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]